Where does Dart NeuroScience, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dart NeuroScience, LLC ranks #22,440 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dart NeuroScience, LLC hold?

Dart NeuroScience, LLC holds 12 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Dart NeuroScience, LLC's Innovation Score?

Dart NeuroScience, LLC has an Innovation Score of 50.5 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dart NeuroScience, LLC focus on?

Dart NeuroScience, LLC's top technology area is C07D (Heterocyclic Compounds) with 11 patents, ranking #741 of 3,165 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Dart NeuroScience, LLC's patent grant rate increasing or decreasing?

Dart NeuroScience, LLC's recent grant velocity is +350% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Dart NeuroScience, LLC's patents?

Dart NeuroScience, LLC's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dart NeuroScience, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dart NeuroScience, LLC

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dart ranks #22,440 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,440
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.5/100): 18.3
avg claims per patent: +350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22440 · US Corporation #22,440 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,440/49,997
PHOTO-FINISH Daikin Manufacturing
CPC-NARROW C07D · 9 areas
INNOV-PAR 50.5/100
CLAIMS-RICH 18.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +350% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Daikin Manufacturing Company, L.P. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dart’s 50.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (18%) Velocity 20.0 pts (40%) Breadth 10.6 pts (21%) Claim depth 11.0 pts (22%)

Qualcomm Incorporated · highest

85
Dart NeuroScience · this assignee

50
Hadasit Medical… · near

50
Luminar · near

50
Repsol · near

50
Watergen · near

50
3D Lighting… · lowest

7

What this shows Dart's Innovation Score is 50.5/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dart?

Each dot is one of Dart’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dart’s own 18.3 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dart vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dart's grants concentrate

Dart NeuroScience, LLC is a focused PatentsView assignee: 9 CPC subclasses with 91.7% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2016. By volume, Dart sits between Dyden Corporation and Davy Process Technology Limited.

Dart's three-year grant acceleration

Dart NeuroScience, LLC shows 7 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dyden

12
DYMO

12
Dynapower

12
Daikin Manufactur…

12
Data Visor

12
Datang NXP Semico…

12
Davro Products

12
Davy Process Tech…

12
Dart Neuroscience ◀

12

What this shows Dart holds 12 patents at rank #22,465, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dart

By rank, the assignees closest to #22,465 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Dart's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dart, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Dart ranks #741 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Watergen Ltd. 50 Repsol S.A. 50 Hadasit Medical Research Services AND Development Ltd. 50 Luminar Technologies, Inc. 50

Dart's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Dart NeuroScience, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	8.3%
2018	1	8.3%
2020	1	8.3%
2021	1	8.3%
2022	3	25.0%
2023	1	8.3%
2024	3	25.0%
2025partial year	1	8.3%

Which technologies does Dart NeuroScience, LLC patent most?

C07D - Heterocyclic Compounds 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C07C - Acyclic OR Carbocyclic Compounds 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dart NeuroScience, LLC's patent record in context - here's where to go next.

Dart NeuroScience, LLC's lead technology class is C07D (Heterocyclic Compounds), 91.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #22,440 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dart NeuroScience, LLC against Dyden Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.